Home/CARsgen Therapeutics/Dr. Raffaele Baffa
DR

Dr. Raffaele Baffa

Chief Medical Officer

CARsgen Therapeutics

Therapeutic Areas

CARsgen Therapeutics Pipeline

DrugIndicationPhase
CT041Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic CancerPhase III
CT011Hepatocellular CarcinomaPhase II
CT053Relapsed/Refractory Multiple MyelomaPhase Ib/II
CT018B-cell Non-Hodgkin LymphomaPhase I
CT059Relapsed/Refractory Multiple MyelomaPhase I
CT017B-cell Non-Hodgkin LymphomaPhase I